Balchem Corp
Research Balchem Corp (BCPC) on Bullrun: valuation model: 5.6% overvalued, market cap USD 5.44B, P/E 34.8, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBCPC
- ExchangeNASDAQ
- CountryUnited States
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyUSD
- Valuation signal5.6% overvalued
- Market capUSD 5.44B
- P/E34.8
- Dividend yield0.6%
- Financial periodFY2025
- RevenueUSD 1.04B
- Revenue growth8.8%
- Net incomeUSD 154.85M
- Gross margin35.7%
Valuation Snapshot
Bullrun's latest valuation model marks Balchem Corp as 5.6% overvalued; latest market cap is USD 5.44B; P/E is 34.8; dividend yield is 0.6%.
About Balchem Corp
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Frequently asked questions
Is Balchem Corp overvalued or undervalued?
Bullrun's valuation model currently marks Balchem Corp as 5.6% overvalued.
What is Balchem Corp's market cap?
Balchem Corp's market capitalization is USD 5.44B.
What is Balchem Corp's P/E ratio?
Balchem Corp's price-to-earnings (P/E) ratio is 34.8.
Does Balchem Corp pay a dividend?
Balchem Corp has a dividend yield of 0.6%.
What does Balchem Corp do?
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.